Cite
HARVARD Citation
Borch, T. et al. (2021). Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma. Journal for immunotherapy of cancer. 9 (7), p. . [Online].